(H-gly-gly-tyr-ala).sup.1 -somatostatin
US3931140A · kind A · utility
8Cited by
3References
5Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Jan 27, 1975 |
| Grant date | Jan 6, 1976 |
| Priority date | — |
| Expiry date | Jan 27, 1995 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S930/16
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The growth hormone release inhibiting compound. ##EQU1## the protamine zinc, protamine aluminum and non-toxic acid addition salts thereof as well as the corresponding linear heptadecapeptide and intermediates therefore are herein described.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.